AI assistant
Sending…
RIGEL PHARMACEUTICALS INC — Director's Dealing 2023
Feb 6, 2023
32801_dirs_2023-02-06_25b8d80c-6e28-4ade-8571-a4367e687a62.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2023-02-02
Reporting Person: Schorno Dean L (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-02 | Common Stock | S | 5389 | $1.6601 | Disposed | 196519 | Direct |
Footnotes
F1: These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.
More from RIGEL PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Proxy Solicitation & Information Statement
2026
Apr 3
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 3
Annual Report
2026
Mar 3
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19